Related Experiment Video

Updated: Jul 8, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection

Hsin Huang1, Stuart H Cohen, Jeff H King

  • 1Infectious Disease, Department of Internal Medicine, University of California, Davis, Medical Center, Sacramento, CA 95817, USA.

Diagnostic Microbiology and Infectious Disease
|January 8, 2008
PubMed

Insights

Injecting drug use significantly increases the risk of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections. Intravenous drug users may act as a reservoir for CA-MRSA, contributing to its spread in urban communities.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a growing public health concern.
  • Identifying risk factors and reservoirs for CA-MRSA is crucial for effective control strategies.

Purpose of the Study:

  • To determine if injecting drug use is a significant risk factor for CA-MRSA infection.
  • To investigate whether injecting drug users serve as a reservoir for CA-MRSA within a community.

Main Methods:

  • A matched case-control study was conducted.
  • Cases were CA-MRSA infected patients; controls included patients with community-associated methicillin-susceptible S. aureus (CA-MSSA) and uninfected individuals.
  • Matching was based on age and isolate culture date.

Main Results:

  • Injecting drug use was associated with a 2.11-fold increased odds of CA-MRSA infection compared to CA-MSSA.
  • Injecting drug use showed a 4.09-fold increased odds of CA-MRSA infection compared to uninfected controls.
  • The findings suggest a strong link between injecting drug use and CA-MRSA acquisition.

Conclusions:

  • Injecting drug use is a significant risk factor for acquiring CA-MRSA infections.
  • Injecting drug users may represent a critical reservoir contributing to the prevalence of CA-MRSA in urban settings.
  • Public health interventions targeting this population may be necessary to curb CA-MRSA spread.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...